peptid bpc 157 BPC-157 / TB-500 Blend (Dual Peptide) BPC-157 Peptide Therapy in Boise

Agrawal V

Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing

It is 1 of 8 B vitamins required by animals for use as a cofactor in DNA synthesis, fatty acid and amino acid metabolism

Clinical Update 10/13/2025 MIND Diet for Cognition